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Predictive value of duplex ultrasound
for restenosis after renal artery stenting
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Abstract. Purpose: Factors predicting renal function and recurrent stenosis following percutaneous renal revascularization are
poorly identified. The predictive value of hemodynamic duplex ultrasound (DUS) parameters was evaluated.
Methods: In a prospective observational study patients undergoing stenting of renal artery stenosis (RAS) were included. Renal
resistance index (RI) and peak systolic velocity (PSV) were measured at baseline, one day, and six months after intervention.
Results: At 6-months follow-up 16 (16.8%) restenosis of 105 treated renal arteries were detected. Baseline RI was 0.69 ± 0.12
and increased significantly to 0.72 ± 0.09 after 6 months (p< 0.0001), however, RI did not predict restenosis. PSV at baseline
and age were independent predictors for increased RI at 6 months (p= 0.0078 and p= 0.0019). Diabetics had a significant higher
RI before revascularization (0.74 ± 0.08) than non-diabetics (0.68 ± 0.12, p= 0.04). PSV after stenting was higher in patients
with restenosis (1.4 ± 0.4 m/sec vs. 1.0 ± 0.3 m/sec, p= 0.002) and was an independent predictor for restenosis.
Conclusions: Increased PSV within the stent one day after the procedure is predictive for restenosis. Patients with high grade
RAS and older patients have a worse outcome. DUS is recommended to detect patients at risk for restenosis after percutaneous
renal revascularization.
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1. Introduction
Atherosclerotic renal artery stenosis (RAS) is a progressive disease leading to renal artery occlusion in
up to 15% within 4 to 7 years [4, 38, 43]. Renal artery stenosis has been known as a cause of hypertension
since the report by Goldblatt more than 70 years ago. He already suggested that patients with unilateral
RAS might be at risk for bilateral renal damage from ischemia on the ipsilateral kidney and from not-
well controlled hypertension on the contralateral side. Patients with RAS have a higher cardiovascular
mortality and atherosclerotic renovascular disease leads to renal failure and is the cause of dialysis in up
to 15% of patients over the age of 50 years [12, 24, 28, 36]. It has been shown that a high grade renal artery
stenosis is a risk factor for renal atrophy and that the loss of renal mass correlates with renal function [5].
However, the relationship between renal ischemia and renal function impairment is not well characterized
since multiple other risk factors for renal atrophy are usually involved. Percutaneous transluminal renal
intervention (PRI) with stent implantation is a safe treatment option with a high short-term and long-term
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technical success rate [2, 13, 40, 42, 45]. Revascularization may lead to better blood pressure control,
regression of left ventricular hypertrophy and improvement of health-related quality of life [46, 49].
Although the progressive nature of the disease has been proven the effect of revascularization on renal
function is still controversial. The goal of many studies was therefore to identify patients who will not
benefit from angioplasty regarding renal function because of irreversible damage of the kidney [34, 46].
Duplex ultrasound (DUS) has a good sensitivity and specificity for the detection of RAS and is usually
recommended as the first diagnostic step [20, 44]. It has the advantage of providing both morphological
and functional assessment of the renal arteries. Direct visualization of the main renal arteries (B-mode
imaging) is combined with measurement (via Doppler) of a variety of hemodynamic factors. Stenotic
lesions can be detected by comparing the systolic flow velocity of the renal artery to that in the aorta, since
the velocity of flow increases as an artery narrows. It has been shown that turbulent flow and changes of
wall shear stress are risk factors for restenosis [1, 8, 23].
High resistance index (RI) in the kidney measured by duplex ultrasound has been proposed as negative
predictor for renal function after PRI. Patients with a RI below 0.8 are more likely to benefit from
endovascular therapy of RAS. However, it has been shown that even in patients with a RI above 0.8
PRI might improve renal function [27, 30, 46]. Renal RI allows identify patients with nephrosclerosis
or glomerulosclerosis and it is correlated with many established cardiovascular risk factors, such as age,
coronary heart disease, increased systolic pressure, diabetes mellitus and decreased renal function [3, 7,
17, 21, 25, 47]. Furthermore, it has been reported that a RI of 0.8 or higher in renal allografts is a strong
predictor of allograft failure and deaths [33]. So far, it is not known if a high RI is predictive for the
development of restenosis after successful revascularization of RAS. In the present study the effect of
revascularization of RAS on RI was prospectively evaluated.
We therefore conducted a prospective observational study based on DUS after stent implantation to
detect local flow alteration. We hypothesized that intrarenal RI and peak systolic velocity of the renal
artery might be predictive for the development of restenosis after stenting.
2. Patients and methods
2.1. Inclusion and exclusion criteria
Between January 2005 and November 2007 patients undergoing revascularization with angioplasty
and stenting of either unilateral or bilateral atherosclerotic ostial renal artery stenosis were included
in the study. In all patients duplex ultrasound was performed by a single experienced investigator at
baseline, one day after and three and six months after the procedure. Patients in whom DUS had not been
performed at our institution or patients not willing to come for follow-up visits were excluded. Indication
for renal artery stenting was (according to the ACC/AHA guidelines 2006) in all cases either unilateral
or bilateral >70% RAS and in addition either uncontrolled hypertension, otherwise unexplained renal
impairment with serum creatinine concentration >1.1 mg/dl or unexplained pulmonary edema.
2.2. Duplex ultrasound (DUS)
DUS was performed with a high end Duplex ultrasound machine (SequoiaTM 512, Acuson Corporation,
Mountain View, CA, USA), using a 4–1 MHz curved transducer. The diagnosis of RAS was based on
duplex ultrasound using peak systolic velocity (PSV) >2.0m/sec and renal-aortic velocity ratio of more
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than 3.5 [6, 9, 15, 22, 31, 33, 35, 37]. Presence of a renal artery stenosis greater than 70% was confirmed
by angiography on visual estimation and in some cases with intraarterial pressure measurement at the
time of the intervention. Intrarenal resistance index (RI) was measured before the intervention and at
each follow-up visit.
Renal artery angioplasty and stenting was performed using guiding catheter technique and implantation
of balloon expandable approved stents [13, 14]. All patients were treated with antiplatelet therapy (aspirin
100 mg) indefinitely and clopidogrel 75 mg for 4 weeks after the procedure.
2.3. Study protocol
Before the intervention and 1 day and 6 months after the procedure Duplex ultrasound of the renal
artery with determination of PSV, RAR and RI of both kidneys were performed as well as measurement of
serum creatinine and blood pressure. Before the intervention cardiovascular risk factors, medical history
and all drugs had been documented and changes were noted at each follow-up visit. The primary end
point was restenosis >70% of the treated renal artery diagnosed by duplex ultrasound (PSV >2.0 m/s).
Correlation of RI, serum creatinine and PSV were analysed. The study had been approved by the Ethical
Committee of Zurich.
2.4. Statistical analysis
Continuous variables are shown as median values with standard deviation. For nominal variables
frequency (n) and relative frequency (%) of binary and nominal variable is given. To identify independent
predictors we performed logistic and linear stepwise regression analysis. To evaluate whether PSV one
day after the intervention can be used as a prognostic factor for restenosis ROC-curve was generated and
we computed the corresponding area under the curve (AUC, 95% confidence interval). Values of p< 0.05
were considered significant.
3. Results
3.1. Study population
A total of 111 patients were screened for study participation. Twenty-four patients had been treated
by angioplasty alone and were therefore not included in the study. Reasons for not implanting a stent
were intolerance of clopidogrel in four patients, in the remaining cases the operator decided not to stent
because of a good result after angioplasty alone.
Eighty-seven patients with 105 lesions were included in the study. In all patients severe renal artery
stenosis had been diagnosed by duplex-ultrasound and was verified by angiography at the time of the
intervention. Baseline characteristics of the patient population are shown in Table 1. There were no
procedure-related deaths or acute stent thrombosis.
3.2. Resistance index (RI) and restenosis after six month
After 6 month DUS in 74 patients demonstrated a non stenotic renal artery. In 13 patients (4 females)
16 (16.8%) restenosis of 105 treated arteries were detected by duplex ultrasound.
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Table 1
Patients characteristics
Patients Restenosis at 6 months
All (n= 87) Yes (n= 13) No (n= 74)
Age, years 69.4 ± 8.6 63.1 ± 12.4 69.2 ± 10.7*
Female, n (%) 35 (40.2) 4 (30.8) 32 (45.7)
Hypertension, n (%) 82 (96.5) 13 (100) 69 (93.2)
Diabetes mellitus, n (%) 18 (20.7) 4 (30.8) 14 (18.9)
Smokers, n (%) 48 (55.1) 7 (53.8) 41 (55.4)
Therapy with statin, n (%) 54 (62.1) 6 (46.2) 48 (64.9)
Therapy with ACE-inhibitor, n (%) 45 (51.7) 7 (53.8) 38 (43.7)
Therapy with beta-blocker, n (%) 58 (66.7) 10 (76.9) 48 (64.9)
Mean serum creatinine, mmol/l 134.0 ± 58.7 113.1 ± 60.8 137.2 ± 60.5*
*p< 0.05.
Mean RI at baseline was 0.69 ± 0.12 and increased significantly to 0.72 ± 0.09 after 6 months
(p< 0.0001). In the group without restenosis after 6 months, RI did not change significantly during
follow-up (RI before: 0.70 ± 0.13, RI 6 months: 0.72 ± 0.01). In patients developing a restenosis after 6
months baseline RI was 0.65 ± 0.1 and increased to 0.68 ± 0.1 at 6 months which was not significant.
Only 17 patients had a RI higher than 0.8 before the intervention, two of them developed restenosis after
6 months. However RI before the intervention was not a predictor for restenosis.
Baseline peak systolic velocity measured by duplex ultrasound (p= 0.0078) and age (p= 0.0019) were
independent predictors for an increased RI 6 months after the intervention indicating that in patients with
very high grade renal artery stenosis before the intervention and older patients have a worse outcome
regarding progressive nephrosclerosis as indicated by RI.
Diabetic patients had a significant higher RI before revascularization (0.74 ± 0.08) than non-diabetic
patients (0.68 ± 0.12, p= 0.04), however in both groups RI did not change significantly after 6 months.
3.3. Postinterventional peak systolic velocity (PSV) and restenosis
In all patients duplex ultrasound was performed one day after the stent implantation with measurement
of PSV. Patients without a restenosis had a PSV of 1.0 ± 0.3 m/sec at the first postinterventional day, in
patients with a restenosis after 6 months PSV was 1.4 ± 0.4 m/sec (p= 0.002). An increased peak systolic
velocity one day after successful stenting of RAS was predictive for the development of a significant
restenosis after 6 months (Figs 1 and 2).
By stepwise logistic regression creatinine level before the intervention was associated with freedom
from restenosis. All other factors did not correlate with restenosis, however, these data are limited since
a large portion of the patients were treated with statins with well controlled cholesterol levels and almost
100% of the patients were hypertensive.
4. Discussion
Atherosclerotic renal artery disease is a progressive disease [5] with an increased cardiovascular and
overall mortality compared to a matched control population [10]. Duplex ultrasound has become one of the
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Fig. 1. Sensitivity and 1-specifity for peak systolic velocity as predictor for restenosis after 6 months. (The colors are visible in
the online version of the article: www.iospress.nl.)
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Fig. 2. Peak systolic velocity in the stent one day after angiographically successful intervention to treat renal artery stenosis is
significant higher in patients with restenosis after 6 months than in patients without restenosis (p= 0.002).
most important techniques to diagnose renal artery disease. In addition, duplex ultrasound allows assessing
renal parenchyma and parenchymal flow patterns. Renovascular resistance index is calculated from
parenchymal end-diastolic and systolic peak velocity and reflects the overall severity of renal parenchymal
disease. RI has been suggested to correlate with clinical outcome after renal artery revascularization.
A strong association was observed by Crutchley et al. between the preoperative RI and all-cause mortality
on follow-up after renal artery revascularization either by stenting or surgical techniques [11]. In addition
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they found in their retrospective study that in patients with severe hypertension with or without renal
insufficiency a RI > 0.8 was associated with a greater than six fold risk of death compared with patients
with a preoperative RI < 0.8. Other authors found in a select group of 566 hypertensive patients without
clinical evidence of atherosclerotic vascular disease that a RI > 0.7 correlated with increased carotid
artery intimal–medial thickness, left ventricular mass index, and echocardiographic evidence of diastolic
dysfunction [41]. These studies indicate that RI is related to morphologic and hemodynamic alteration
of the cardiovascular system and may even provide an accurate estimate of overall risk. We therefore
evaluated RI in 87 patients undergoing renal artery stenting to test, if RI is predictive for restenosis. The
restenosis rate in our patient group was 16.8% which is in accordance to other published results [19, 48].
Baseline RI was not a predictor for restenosis at 6 month, however only 17 patients with RI above 0.8
were included, only two of them developed a restenosis. The result may have been different, if a greater
number of patients with RI > 0.8 were treated.
As expected, diabetic patients had a higher RI than non-diabetic patients; however diabetes was not
associated with higher restenosis rate. Interestingly, patients without restenosis had higher baseline crea-
tinine levels. The clinical impact of this finding might be that renal artery stenting can be performed with
good long-term result regarding patency even in patients with impaired renal function.
Despite technical successful revascularization correction of hypertension and improvement of renal
function might not always be achieved. Therefore, parameters to identify patients who will benefit from
revascularization have been proposed [18, 29, 32]. There are controversial publications about the predic-
tive value of baseline RI regarding blood pressure control and renal function after stenting of RAS. In
our study we characterized patients in which RI increased over time despite successful stenting of RAS.
We analyzed cardiovascular risk factors as well as duplex criteria at baseline and found that only age and
PSV were independent associated with an increase in RI after 6 months. Higher PSV is indicating a more
severe stenosis and therefore renal parenchymal damage is more pronounced. This result is supported by
a study on the natural history of RAS from Caps et al. [5] RAS is a progressive disease with shrinking of
the kidneys and progressive loss of renal function. Therefore, delayed revascularization of RAS is more
likely to be associated with irreversible nephrosclerosis.
Although restenosis is not a major problem in renal arteries, we still need technical improvements to
further reduce restenosis rate. We found that PSV in the stent one day after the intervention is predictive
for restenosis. This finding is especially interesting, since in our analysis only patients with less than 20%
residual stenosis in the postinterventional angiography had been included. According to the duplex criteria
for renal arteries a PSV between 1.8 and 2 m/sec is considered a significant stenosis [20, 26]. However,
in patients with restenosis after 6 month mean PSV at the first postinterventional day was 1.4 m/sec
whereas in patients without restenosis PSV was only 1.0 m/sec. This underlies the importance of optimal
stent deployment and sizing, since even small turbulences in the stent may promote the development of
restenosis. It has already been suggested that clinical outcome of renal artery stenting depends on the
hemodynamic result of the procedure [16, 39]. Insufficient hemodynamic result after stenting of RAS can
be detected by an early postinterventional duplex ultrasound even in cases with angiographically good
result. Disturbed flow in the stent might be one reason for insufficient clinical success regarding blood
pressure control and renal function after percutaneous intervention for RAS.
5. Conclusion
Early postinterventional duplex ultrasound with measurement of PSV in the stent may be useful to
identify patients at higher risk for recurrent stenosis and should therefore be recommended. The result
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of this study suggests that optimal stent sizing and deployment is crucial to further reduce restenosis rate
in renal arteries However, increased RI is not associated with a higher rate of restenosis after stenting of
atherosclerotic RAS. In the present study high grade renal artery stenosis before stenting was predictive
for a further increase of RI suggesting that if treatment of RAS is delayed irreversible damage of renal
parenchyma takes place.
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